These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6474581)

  • 21. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.
    Ganapathi R; Reiter W; Krishan A
    J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52.
    Shinoda H; Inaba M; Tsuruo T
    Cancer Res; 1989 Apr; 49(7):1722-6. PubMed ID: 2924316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo response of mitoxantrone and doxorubicin with dipyrone in parental and doxorubicin-resistant P388 leukemia.
    Kamath NS; Chitnis MP
    Oncology; 1990; 47(2):166-9. PubMed ID: 2314829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors governing the modulation of vinca-alkaloid resistance in doxorubicin-resistant cells by the calmodulin inhibitor trifluoperazine.
    Ganapathi R; Grabowski D; Schmidt H
    Biochem Pharmacol; 1986 Feb; 35(4):673-8. PubMed ID: 3947398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effect of collaterally sensitive antimetabolites on P388 murine leukemia sensitive and resistant to adriamycin in vitro.
    Satyamoorthy K; Deshpande SS; Chitnis MP
    Neoplasma; 1989; 36(6):673-83. PubMed ID: 2515459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-resistance of vincristine-resistant sublines of P388 leukemia to mitoxantrone with special emphasis on the relationship between in vitro and in vivo cross-resistance.
    Inaba M; Nagashima K; Sakurai Y
    Gan; 1984 Jul; 75(7):625-30. PubMed ID: 6468847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.
    Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Res; 1981 May; 41(5):1967-72. PubMed ID: 7214365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoration of drug sensitivity by nitroxazepine hydrochloride in P388 murine leukemia cells resistant to adriamycin.
    Chitnis MP; Pradhan SG; Satyamoorthy K; Basrur VS
    Cancer Drug Deliv; 1987; 4(1):1-9. PubMed ID: 3607719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Tween 80 on adriamycin cytotoxicity in murine P388 leukemia.
    Chitnis MP; Menon RS; Gude RP
    Tumori; 1984 Aug; 70(4):313-5. PubMed ID: 6474580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Murine and human leukemias.
    Burchenal JH
    Bibl Haematol; 1975; (40):665-77. PubMed ID: 1100047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of multidrug resistance by a novel quinoline derivative, MS-209.
    Sato W; Fukazawa N; Nakanishi O; Baba M; Suzuki T; Yano O; Naito M; Tsuruo T
    Cancer Chemother Pharmacol; 1995; 35(4):271-7. PubMed ID: 7828268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circumvention of adriamycin resistance: effect of 2-methyl-1,4-naphthoquinone (vitamin K3) on drug cytotoxicity in sensitive and MDR P388 leukemia cells.
    Parekh HK; Mansuri-Torshizi H; Srivastava TS; Chitnis MP
    Cancer Lett; 1992 Jan; 61(2):147-56. PubMed ID: 1730138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of in vitro chemosensitivity by extracellular Ca++ in adriamycin sensitive and resistant P388 leukemic cells.
    Adwankar MK; Chitnis MP
    Neoplasma; 1990; 37(1):31-6. PubMed ID: 2320178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical parameters of resistance of an adriamycin-resistant subline of P388 leukemia to emetine, an inhibitor of protein synthesis.
    Chitnis MP; Johnson RK
    J Natl Cancer Inst; 1978 May; 60(5):1049-54. PubMed ID: 642026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simple fluorometric method to discriminate adriamycin-resistant subline from adriamycin-sensitive parental P388 murine leukemia cell line.
    Dekker K; Kojima N; Yamamoto S; Tatsumi K; Mino M; Yagi K
    Biochem Int; 1987 Jun; 14(6):997-1001. PubMed ID: 3453100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor drug cross-resistance in vivo in a murine P388 leukemia resistant to ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7 - ylcarbamate 2-hydroxyethanesulfonate hydrate (NSC 370,147) 370147.
    Waud WR; Harrison SD; Temple CG; Griswold DP
    Cancer Chemother Pharmacol; 1992; 29(3):190-4. PubMed ID: 1733551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug resistance studies on intraspecific hybridomas.
    Pályi I; Turi G; Szikla K; Dallmann L
    Arch Geschwulstforsch; 1981; 51(1):119-24. PubMed ID: 7259434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.
    Inaba M; Kobayashi H; Sakurai Y; Johnson RK
    Cancer Res; 1979 Jun; 39(6 Pt 1):2200-3. PubMed ID: 445418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of anthracyclines against an adriamycin (NSC-123127)-resistant subline of P388 leukemia with special emphasis on cinerubin A (NSC-18334).
    Johnson RK; Ovejera AA; Goldin A
    Cancer Treat Rep; 1976 Jan; 60(1):99-102. PubMed ID: 826316
    [No Abstract]   [Full Text] [Related]  

  • 40. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline.
    Ramu N; Ramu A; Cole DE; Balis FM; Poplack DG; Pollard HB
    Isr J Med Sci; 1988; 24(9-10):477-82. PubMed ID: 2974448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.